GlaxoSmithKline

Breakout Stocks: How to trade JK Cement, AstraZeneca Pharma & GlaxoSmithKline Pharma that hit… The Times of India13:34
Alector concludes enrolment in Phase II trial of Alzheimer’s treatment Clinical Trials Arena10:00
Incretin-based drugs market Forecast report 2025-2034 featuring AstraZeneca, boehringer… Business Wire (Press Release)15:27
Bayer, GSK and other pharma giants sued in latest life sciences Npe assertions IAM13:46
GSK Pharma surges 10%, stock hits all-time high; Buy, sell or hold? The Business Standard06:48
GSK’s Blenrep combinations approved by MHRA to treat multiple myeloma PMLiVE12:35

Latest News

Yesterday
Breakout Stocks: How to trade JK Cement, AstraZeneca Pharma & GlaxoSmithKline Pharma that hit… The Times of India13:34 24-Apr-25
GSK Pharma surges 10%, stock hits all-time high; Buy, sell or hold? The Business Standard06:48 24-Apr-25
In the last 7 days
Incretin-based Drugs Market Forecast Report 2025-2034 Featuring AstraZeneca, Boehringer… Business Wire (Press Release)15:27 23-Apr-25
Bayer, GSK and other pharma giants sued in latest life sciences NPE assertions IAM13:46 22-Apr-25
GSK’s Blenrep combinations approved by MHRA to treat multiple myeloma PMLiVE12:35 22-Apr-25
Alector concludes enrolment in Phase II trial of Alzheimer’s treatment Clinical Trials Arena10:00 22-Apr-25
GSK Enhances Shareholder Value with Strategic Buyback TipRanks07:21 22-Apr-25
United States Pain Management Therapeutics Market Forecast Report and Company Analysis 2025-2033 Featuring Eli Lilly… GlobeNewswire (Press Release)16:33 21-Apr-25
UK’s MHRA authorises GSK’s Blenrep for multiple myeloma treatment Pharmaceutical Technology12:54 21-Apr-25
GSK cements Blenrep comeback with MHRA approval pharmaphorum17:09 18-Apr-25
GSK opens vaccine distribution centre in Abu Dhabi The Stat Trade Times05:38 18-Apr-25
In the last month
US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's Rsv Vaccines For Older Adults Below 60 Years Benzinga20:48 17-Apr-25
GSK kicks off Blenrep's market return with first myeloma combo nod in UK FiercePharma20:37 17-Apr-25
GSK Zantac Appeal Gets Tough Questions From Some US Judges Insurance Claims Journal19:28 17-Apr-25
Guru Fundamental Report for GSK Nasdaq19:25 17-Apr-25
GSK's myeloma drug Blenrep wins authorization from UK regulators ENDPOINTS18:17 17-Apr-25
GSK receives approval from UK Mhra for Blenrep combination London South East17:11 17-Apr-25
GSK’s Blenrep Combinations Approved in UK for Multiple Myeloma TipRanks16:26 17-Apr-25
RSV shots from GSK, Pfizer get potential boost from broadened ACIP guidance FiercePharma16:14 17-Apr-25
GSK Executives Increase Share Interests Following Dividend Reinvestment TipRanks15:35 17-Apr-25
GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59 Zacks15:23 17-Apr-25
GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP Zacks15:23 17-Apr-25
GSK’s five-in-one meningococcal vaccine recommended by CDC advisory committee PMLiVE12:47 17-Apr-25
GSK reprimanded over "shocking error" in Omjjara info pharmaphorum12:41 17-Apr-25
Why your pensions could be dealt a body blow as Donald Trump eyes devastating tariffs for Britain's top pharmaceutical… This is Money09:35 17-Apr-25
GSK gets US advisory panel backing for Rsv and Meningitis vaccines London South East09:23 17-Apr-25
Two GSK vaccines get US CDC recommendations ShareCast09:12 17-Apr-25
ACIP recommends GSK’s RSV vaccine for at-risk adults 50 to 59 Pharmaceutical Technology08:35 17-Apr-25
Sainsbury's full-year sales rise, US CDC recommends two GSK vaccines ShareCast07:36 17-Apr-25
GSK’s RSV Vaccine Gains Key Recommendation for Broader Adult Use TipRanks07:28 17-Apr-25
GSK’s Penmenvy Vaccine Gains US Advisory Committee’s Endorsement TipRanks07:28 17-Apr-25
GSK Expands Share Buyback Program with Latest Purchase TipRanks07:18 17-Apr-25
Trend turns favourable for GlaxoSmithKline Pharma, key levels to track The Business Standard06:59 17-Apr-25
Arexvy recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US… GlaxoSmithKline (Press Release)22:11 16-Apr-25
GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization … GlaxoSmithKline (Press Release)21:51 16-Apr-25
GSK scolded after complainant flags ‘shocking error’ in prescribing information FiercePharma16:19 16-Apr-25
Abu Dhabi to launch multi-omics research institute in partnership with GSK BioSpectrum Asia14:54 16-Apr-25
GSK Executives Acquire Shares Following Dividend Reinvestment TipRanks15:37 15-Apr-25
Were we right to ditch our GSK shares? Motley Fool (UK)07:01 15-Apr-25
Korean regulator releases post-marketing survey results on GSK’s Trelegy adverse reactions Korea Biomedical Review02:43 15-Apr-25
New pill is effective against gonorrhea as antibiotic resistance surges: Study NBC Connecticut19:12 14-Apr-25
GSK Directors Acquire Shares Through Dividend Reinvestment TipRanks15:33 14-Apr-25
Eeva Hakoranta leaving InterDigital; Ericsson joins Avanci Video; Pfizer agrees GSK royalties; Wilus-Lenovo Wi-Fi 6… IAM11:58 13-Apr-25
GSK3β identified as a driver of drug resistance in BRAF mutant melanoma News-Medical.Net17:31 11-Apr-25
Fierce Pharma Asia—Congress' US-China biotech report; NIH's database ban; GSK's ABL… FiercePharma15:36 11-Apr-25
GSK Executives Acquire Shares Under Reward Plan TipRanks15:32 11-Apr-25
Ira Mellman joins PICI; ViiV Healthcare CMO replaces Chris Corsico at GSK ENDPOINTS12:03 11-Apr-25
Antiviral Drugs Market Forecasts and Company Analysis 2025-2034 Featuring AbbVie, Aurobindo, BMS, Cipla, Dr. Reddy's,… GlobeNewswire (Press Release)15:03 10-Apr-25
AstraZeneca and GSK retain defensive qualities, but tariff assault on sector could change that Proactive Investors (UK)12:14 10-Apr-25
ABL Bio held back its top Alzheimer’s targets. GSK still signed a $2.7 bil. licensing deal. Korea Biomedical Review01:30 10-Apr-25
Tariff fears wipe £14bn of UK pharma stocks: AstraZeneca and GSK tumble after Trump threats This is Money22:17 9-Apr-25
FTSE 100 rocked as US 'reciprocal' tariffs kick in and China hikes in response Proactive Investors (UK)16:46 9-Apr-25
GSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional… Business Wire (Press Release)15:03 9-Apr-25
Bernstein Litowitz, Kessler Topaz Seek To Lead GSK Investors Law36021:01 8-Apr-25
GSK, ABL Bio Ink Up-to-$2.75B+ Neurodegenerative Collaboration Genetic Engineering and Biotechnology News19:57 8-Apr-25
ABL Bio and GSK ink $2.5b neurodegeneration deal Longevity Technology16:57 8-Apr-25
GSK and Pfizer Stipulate to Dismissal of RSV Vaccines Lawsuit JD Supra16:48 8-Apr-25
Pfizer agrees to pay GSK royalties as part of global RSV patent settlement IAM12:19 8-Apr-25
Companies roundup: GSK & Staffline Investors Chronicle12:08 8-Apr-25
GSK to advance antibody medicines for neurodegenerative diseases European Pharmaceutical Review11:24 8-Apr-25
ABL lands £2B deal with GSK based on BBB passing drug platform BioWorld22:03 7-Apr-25
GSK targets neurodegenerative diseases with latest licensing deal BioPharma Dive17:19 7-Apr-25
GSK Ramps Up Neuroscience Investment With ABL Brain Shuttle Deal Scrip Pharma Intelligence16:45 7-Apr-25
GSK makes fresh neuroscience foray with £2bn+ ABL deal pharmaphorum14:28 7-Apr-25
GSK and ABL Bio enter neurodegenerative disease agreement worth over £2bn PMLiVE12:55 7-Apr-25
ABL Bio and GSK link on neurodegenerative conditions Pharmaceutical Technology09:50 7-Apr-25
GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm PR Newswire (Press Release)07:58 7-Apr-25
GSK Executes Share Buyback to Enhance Shareholder Value TipRanks07:18 7-Apr-25
GSK signs £2 B deal with Korean startup ABL Bio for treatment of neurodegenerative diseases BioSpectrum Asia06:56 7-Apr-25
GSK’s newest neuro pact is with ABL Bio, a Sanofi-partnered South Korean biotech ENDPOINTS06:53 7-Apr-25
ABL Bio spikes 30% on $2.7 bil. GSK licensing deal for BBB-shuttling brain drugs Korea Biomedical Review03:20 7-Apr-25
ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel … PR Newswire (Press Release)01:04 7-Apr-25
British drugs giant accused of hiding link between heartburn medicine and cancer MailOnline22:09 5-Apr-25
GSK Inks $67M Deal To Resolve Zantac Cancer Risk FCA Suit Law36022:01 4-Apr-25
GSK and Pfizer resolve RSV vaccine patent fight ENDPOINTS20:43 4-Apr-25
GSK, Pfizer Agree to End Patent Lawsuit Over Rival RSV Vaccines Bloomberg Law20:36 4-Apr-25
Deadline Soon: GSK plc. (GSK) Investors Who Lost Money Urged To Contact The Law Offices of… Business Wire (Press Release)17:03 4-Apr-25
GSK, Pfizer resolve RSV patent feud amid vaccine market uncertainty FiercePharma16:02 4-Apr-25
GSK: Under Threat From 'Double Whammy' Of Vaccine Skepticism And Pharma Tariffs Seeking Alpha13:02 4-Apr-25
GSK Enhances Shareholder Value with Strategic Share Buyback TipRanks07:14 4-Apr-25
GSK, Pfizer Agree To End Patent Fight Over RSV Vaccines Law36004:43 4-Apr-25
GSK resolves patent lawsuit against Pfizer over Rsv vaccines Yahoo! US23:44 3-Apr-25
New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops Benzinga20:20 3-Apr-25
GSK Deadline: Rosen Law Firm Urges GSK plc (NYSE: GSK) Investors with Losses in Excess of $100K … Business Wire (Press Release)16:58 3-Apr-25
UK pharma escapes worst of Trump tariffs (for now) but uncertainty may keep pressure on shares Proactive Investors (US)14:35 3-Apr-25
UK pharma stocks avoid selloff London South East10:38 3-Apr-25
AstraZeneca and GSK shares rise on possible escape from new US tariffs Proactive Investors (UK)10:13 3-Apr-25
FTSE 100 pharma giants GSK and Astrazeneca appear to swerve Trump tariffs City AM09:21 3-Apr-25
Esophageal Cancer Market research 2024-2032 Featuring AstraZeneca, Takeda, Pfizer, Novartis, Amgen, Bristol-Myers… GlobeNewswire (Press Release)09:06 3-Apr-25
GSK Expands Share Buyback Program with Recent Purchase TipRanks07:20 3-Apr-25
FTSE 100 movers: Rolls-Royce, GSK pace losses ShareCast00:03 3-Apr-25
GSK deadline: Rosen, A ranked and leading law firm, Encourages GSK plc Investors with Losses in Excess of $100K to… GlobeNewswire (Press Release)19:31 2-Apr-25
Ongoing deadline alert: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GSK GlobeNewswire (Press Release)16:41 2-Apr-25
Camden employers unveil masterplan to tackle air pollution Air Quality News13:52 2-Apr-25
GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t… Fortune12:52 2-Apr-25
GSK’s share price looks a steal to me anywhere below £43.29, and here’s why Motley Fool (UK)08:01 2-Apr-25
NAT10 promotes the progression of clear cell renal cell carcinoma by regulating ac4C acetylation of NFE2L3 and… Nature.com00:30 2-Apr-25
GSK plc Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your… GlobeNewswire (Press Release)18:33 1-Apr-25
GSK Announces Total Voting Rights and Capital Update TipRanks15:37 1-Apr-25
Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSK Pharmaceutical Technology12:37 1-Apr-25
Sanofi continues its bet on R&D by poaching GSK’s head of development ENDPOINTS11:42 1-Apr-25
GSK Korea's long-acting HIV injection therapy gains insurance benefit Korea Biomedical Review09:19 1-Apr-25
GSK Enhances Share Buyback Program with Latest Purchase TipRanks07:19 1-Apr-25
GSK is investigating if shingles vaccine reduces risk of dementia Skeptical Raptor21:12 31-Mar-25
Deadline alert for Mpwr, GSK, and Iclr: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf… GlobeNewswire (Press Release)17:46 31-Mar-25
GSK important deadline: Rosen, national investor counsel, Encourages GSK plc Investors to Secure Counsel Before… GlobeNewswire (Press Release)21:33 30-Mar-25
Does the shingles jab slash your risk of dementia? Drugs giant GSK launches ground-breaking… MailOnline02:36 30-Mar-25
GSK Deadline: GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit PR Newswire (Press Release)21:45 28-Mar-25
Deadline Alert: GSK plc. (GSK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities… GlobeNewswire (Press Release)17:41 28-Mar-25
GSK Announces Release of ADSs for Non-Executive Directors TipRanks15:47 28-Mar-25
GSK Wants UK to Open Up Health Records to Boost Drug Development Bloomberg Law09:50 28-Mar-25
Three momentum stocks for 2025 The Financial Express01:17 28-Mar-25
GSK final deadline: Rosen, Recognized investor counsel, Encourages GSK plc Investors to Secure Counsel Before Important … GlobeNewswire (Press Release)22:52 27-Mar-25
Deregulation boosts pharma profits by 210% YoY The Express Tribune22:23 27-Mar-25
GSK tip claiming Pfizer delayed COVID vaccine results during 2020 election prompts US probe: WSJ FiercePharma16:00 27-Mar-25

      
            
      
    view more headlines
   
      
      
      
24 Apr 13:34
   

GlaxoSmithKline News

NewsNow aims to be the world's most accurate and comprehensive aggregator of GlaxoSmithKline news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

GlaxoSmithKline

Latest News

GlaxoSmithKline News

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories